1.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: any age
Sponsor: NCI
Protocol IDs: CLB-9583, NCT00002760, CALGB-9583
|
|
2.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: MDA-DM-95231, NCI-G96-1044, NCT00002855
|
|
3.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: RTOG-P-0014, RTOG-DEV-1028, ECOG-RTOG-P-0014, CALGB-RTOG-P-0014, SWOG-RTOG-P-0014, NCT00030654
|
|
4.
|
Phase: Phase III
Type: Supportive care
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCI-81-C-189, NCI-POB-8103
|
|
5.
|
Phase: Phase III
Type: Supportive care
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: UMCC-8107
|
|
6.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000069088, E1899, SWOG-E1899, CALGB-E1899, NCT00027859
|
|
7.
|
Phase: Phase II, Phase I
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CRB-9202, NCI-T94-0090N, T94-0090
|
|
8.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: AECM-03099, AECM-CA163402, AECM-NMC-03-10-277C, NCT00096317
|
|
9.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: MDA-DM-95010, NCI-T95-0012D, T95-0012
|
|
10.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: PCI-9437, NCI-T94-0173D, T94-0173
|
|
11.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MDA-DM-97022, NCI-T97-0023, NCT00003084, T97-0023
|
|
12.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-99-C-0052, NCT00019695
|
|
13.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: NCI
Protocol IDs: MCC-12219, MCC-IRB-5722, NCI-G00-1863, NCT00006371
|
|
14.
|
Phase: Phase II
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-00113, NCI-G01-1927, NCT00014352
|
|
15.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCOG-P-4P831, NCOG-P-4P-83-1
|
|
16.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: WCCC-CO-8586, NCI-T86-0145D, T86-0145
|
|
17.
|
Phase: Phase II
Type: Supportive care
Status: Completed
Age: any age
Sponsor: NCI
Protocol IDs: NCI-85-C-212C, NCI-T86-0036N, T86-0036
|
|
18.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-90-C-191G, NCI-T90-0219N, T90-0219
|
|
19.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: CAN-OTT-9008, NCI-V91-0084
|
|
20.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor:
Protocol IDs: NCI-91-C-223
|
|
21.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: Any age
Sponsor: NCI
Protocol IDs: MDA-DM-98223
|
|
22.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: Not specified
Sponsor: NCI
Protocol IDs: MDA-ID-99061
|
|
23.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: Not specified
Sponsor: NCI
Protocol IDs: UCSF-035516, UCSF-H45860-23833-02, NCT00309894
|
|
24.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 01253 - Committee 1, FHCRC-05026, 05-8538-V 01, 28741-A, NCT00298155
|
|
25.
|
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000540496, CASE-12805, CELGENE-CASE-12805, NCT00460031
|
